Eylea 2 mg/0.05 mL injection Images
Generic Name: aflibercept
This medication has been identified as Eylea 2 mg/0.05 mL injection. It is supplied by Regeneron Pharmaceuticals, Inc.
Eylea is used in the treatment of Macular Degeneration; Macular Edema; Diabetic Retinopathy; Retinopathy of Prematurity; Diabetic Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Eylea 2 mg/0.05 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Eylea
- Generic Name
- aflibercept
- Strength
- 2 mg/0.05 mL injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Regeneron Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 61755-0005
More about Eylea (aflibercept ophthalmic)
- Compare alternatives
- Pricing & coupons
- Reviews (52)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.